Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
about
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaMechanisms of cellular invasion by intracellular parasitesRecent insights into apicomplexan parasite egress provide new views to a killThe malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisinProcessing of Plasmodium falciparum Merozoite Surface Protein MSP1 Activates a Spectrin-Binding Function Enabling Parasite Egress from RBCsThe malarial serine protease SUB1 plays an essential role in parasite liver stage developmentProtease inhibitors from marine actinobacteria as a potential source for antimalarial compoundPlasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycleHorizontal transfer of a subtilisin gene from plants into an ancestor of the plant pathogenic fungal genus ColletotrichumIn Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compoundProteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.Molecular determinants of binding to the Plasmodium subtilisin-like protease 1.In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitorsSerine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets.From crystal to compound: structure-based antimalarial drug discovery.Plasmodium berghei PIMMS2 promotes ookinete invasion of the Anopheles gambiae mosquito midgut.A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.Plasmodium falciparum subtilisin-like protease 1: discovery of potent difluorostatone-based inhibitors
P2860
Q26772878-84ED74B4-4D12-403B-828E-395466291FBBQ27010243-F6F4A6EF-A1E1-4992-B5C2-2E60B4B751F3Q27023611-B2B93068-039D-4E33-B52E-DA10D2EAE364Q27683602-D27D49AA-5AD3-46D5-9624-EFFA39D95A8CQ27972787-4E640B3F-6B7E-491E-98CF-63CFF6120FD5Q28537649-DF85A327-A116-48AC-AFA9-1B4E96A6790AQ28540732-BE237D4F-4554-4CF0-9E82-DBFBF6A3B4F7Q30046956-3AB41711-D240-419E-9A16-C39EFD004BBCQ34648716-661C598C-968F-4591-B10F-E051984B9BA5Q34709772-7DC921EB-7CAD-4D96-8A32-439A1A45246CQ36368252-63C9177D-958B-4BDA-AA42-B05549E53DDFQ36716475-1F2EE212-A074-438C-B05A-AF4A04999FE9Q37611650-29D245C5-0853-49B6-891D-4D9ACE2E8245Q37706424-09CAD20A-0663-4C8A-97E7-5C457CA23EDFQ38227796-DCCD3A58-4196-48DD-BCFB-40230FCC4C6FQ38755598-1272CA07-BFC2-4775-AA73-50D7F7FFB3DDQ47597994-CC0ED11F-A906-4F08-B725-F8F70B0959FFQ58855663-5A842333-D2AE-4DF2-A734-B4C7E0798BC4
P2860
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@ast
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@en
type
label
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@ast
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@en
prefLabel
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@ast
Plasmodium subtilisin-like pro ...... of a pan-malaria drug target.
@en
P2093
P2860
P50
P1476
Plasmodium subtilisin-like pro ...... n of a pan-malaria drug target
@en
P2093
Aigars Jirgensons
Chrislaine Withers-Martinez
Fiona Hackett
Maria Penzo
Michael J Blackman
Samir Kher
Simone Fulle
P2860
P304
P356
10.1016/J.IJPARA.2012.04.005
P577
2012-04-27T00:00:00Z